CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-18 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −10,000 | $180.00 | $1.8M | 15,000 |
| 2025-09-18 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −14,473 | $180.13 | $2.6M | 2,346,379 |
| 2025-09-17 | Sheena Jonathan Director | Sale 10b5-1 | −2,814 | $175.88 | $495K | 239,438 |
| 2025-09-17 | Sheena Jonathan Director | Sale 10b5-1 | −256 | $176.61 | $45K | 239,182 |
| 2025-09-15 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Gift | −300 | 120,559 | ||
| 2025-09-12 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −4,500 | $170.31 | $766K | 25,500 |
| 2025-09-12 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −500 | $172.64 | $86K | 25,000 |
Page 39 of 39 · 767 trades